Total Funding
61
47
Total FundingGrant raised
Growth Score
-4 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
173051
Oscillo Biosciences is a biotech company that restores memory in people with alzheimers disease and dementia.
Mark Costanzo: CFO
Brian Groch: Chief Operating OfficerPast Role: Shield Therapeutics, President and Chief Commercial Officer
About the Company
Oscillo Biosciences develop pharmacological treatments for Alzheimer's disease and related disorders. Oscillo Biosciences conducted a phase 1 study to evaluate the effectiveness of music and multisensory stimulation on brain activity in adults. Oscillo Biosciences creates a prescription medical device and a digital therapeutic that work
together to restore healthy brain function in patients suffering from mild cognitive impairment and Alzheimer's disease. The approach of Oscillo Biosciences is based on the understanding that brain rhythms supporting memory and cognition are disrupted in people with Alzheimer's disease.
